Pericellulars substrates of human mast cell tryptase: 72,000 Dalton gelatinase and fibronectin

Journal of Cellular Biochemistry

Volumn 50, Issue 4, 1992, Pages 337-349

  Lohi, Jouko ^a   Kesksi‐Oja, Jorma ^a   Harvima, Ilkka ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

basement membrane; fibronectin; gelatinase; mast cell; pericellular matrix; proenzyme activation; tryptase; type IV collagenase

Indexed keywords

MEMBRANE PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 2; TRYPTASE;

ARTICLE; BASEMENT MEMBRANE; CELL MEMBRANE; ENZYME ACTIVITY; FIBROBLAST; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; MAST CELL; MEMBRANE DAMAGE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

CELL LINE; EDETIC ACID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EMBRYO; FIBROBLASTS; FIBRONECTINS; GELATINASE A; GELATINASES; HUMAN; LUNG; MAST CELLS; METALLOENDOPEPTIDASES; MOLECULAR WEIGHT; PEPTIDE FRAGMENTS; PROTEASE INHIBITORS; SERINE ENDOPEPTIDASES; SUBSTRATE SPECIFICITY; SUPPORT, NON-U.S. GOV'T;

GLYCINE MAX;

EID: 0026677848     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.240500402     Document Type: Article

References (58)

1. Mast cell heterogeneity in man, I. Histologic studies of the intestine
2. The activation of latent pig synovial collagenase
3. H‐ras oncogene‐transformed human bronchial epithelial cells (TEB‐1) secrete a single metalloprotease capable of degrading basement membrane collagen
4. Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation
5. Domain structure of human 72‐kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase‐2 (TIMP‐2) binding regions
6. Human plasma fibronectin as a substrate for human urokinase
7. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation
8. The allosteric effect of salt on human mast cell tryptase
9. Human skin tryptase: Purification, partial characterization and comparison with human lung tryptase
10. Isolation of the pericellular matrix of human fibroblase cultures
11. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase
12. Regulation of the autoactivation of human 72‐kDa Progelatinase by tissue inhibitor of metalloproteinases‐2
13. Monoclonal antibodies to type IV collagenase recognize a protein with limited sequence homology to interstitial collagenase and stromelysin
14. Structure of the human type IV collagenase gene
15. Complete structure of the human gene for 92‐kDa type IV collagenase: Divergent regulation of expression for the 92‐kDa and 72 kDa enzymes genes in HT‐1080 cells
16. Human lung mast cell tryptase fails to activate procollagenase or degrade proteoglycan
17. Characterization of a novel gelatin‐binding 21 kDa protein secreted by cultured adherent cells
18. Specific effects of fibronectin‐releasing peptides on the extracellular matrices of cultured human fibroblasts
19. Thrombin affects fibronectin and procollagen in the pericellular matrix of cultured human fibroblasts
20. The cellular target for the plasminogen activator, urokinase, in human fibroblasts‐66,000‐dalton protein
21. Chymotryspinand trypsin‐type serine proteases in rat mast cells: Properties and functions
22. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
23. Growths factors in the regulation of pericellular proteolysis: A review
24. Enhanced production and extracellular deposition of the endothelial‐type plasminogen activator inhibitor in cultured human lung fibroblast by transforming growth factor‐β
25. Transforming growth factor‐β alter plasminogen activator activity in human skin fibroblast
26. Production of gelatin‐degrading matrix metalloproteinases (“type IV collagenases”) and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin‐1 and tumor necrosis factor α
27. Metastatic potential correllates with enzymatic degradation of basement membrane collagen
28. Partial purification and characterization of neutral protease which cleaves type IV collagen
29. Pericellular substrates of human mast cell tryptase: 66 kDa gelatinase and fibronectin
30. Gelatinase (type IV collagenase) immunolocalization in cells and tissues: Use of an antiserum to rabbit bone gelatinase that identifies high and low M, forms
31. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymatic properties
32. A metalloproteinases from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization
33. Independent regulation of collagenase, 72‐kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblast by transforming growth factor‐β
34. Transcriptional and post‐transcriptional regulation of 72‐kDa gelatinase/type IV collagenase by transforming growth factor‐β1 in human fibroblasts
35. Living histamine containing cells from the bronchial lumens of human. Description and comparison of histamine content with cells of rhesus monkeys
36. Limited cleavages of cellular fibronectin by plasminogen activator purified from transformed cells
37. Production of basement membrane collagen degrading enzyme and plasminogne activator by transformed cells‐role in metastasis
38. Regulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer
39. The major enzymes of human mast cell secretory granules
40. Tryptase from human pulmonary mast cells, purification and characterization
41. Human lungs mast cells: Distribution and abundance of histochemically distinct subpopulations
42. Cutaneous necrotizing venulitis: Avenulitis: An analysis of the morphological alterations occurring after mast cell degranulation in a patient with unique syndrome
43. The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation
44. Human skin fibroblast procollagenase: Mechanisms of activation by organomercurials and trypsin
45. A new principle of regulation of enzymatic activity. Activation of human polymorphonuclear leucocyte collagenase via disulphide‐thiol exchange as catalysed by the glutathione cycle in a peroxidase‐coupled reaction to glucose metabolism
46. Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene‐transformed human bronchial epithelial cells
47. Multiple steps in the activation of the inactive precursor of bone collagenase by trypsin
48. Characterization of the binding domains in the fragments cleaved by cathespin G from human plasma fibronectin
49. Human gelatinase/type IV procollagenase is a regular plasma component
50. Human macrophages synthesis and secrete a major 95,000‐dalton gelatinbinding protein distinct from fibronectin
51. Susceptibility of soluble and matrix fibronectins to degradation by tissue protein ases, mast cell chymase and cathepsin G
52. A gelatin‐binding 70,000‐dalton glycoprotein synthesized distinctly from fibronectin by normal and malignant adherent cells
53. Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for role of plasminogen activator
54. Stimulation by endocytosis of the secretion of collagenase and neutral proteinase from rabbit synovial fibroblasts
55. Matrix metalloproteinases and their inhibitors in connective tissue remodelling
56. Fibronectin domains and receptors